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Abstract Using a combination of stopped-flow spectrophoto-
metric proton pumping measurements and time-resolved poten-
tial measurements on black lipid membranes, we have
investigated the effect of Zn2+ ions on the proton transfer
properties of Paracoccus denitrificans cytochrome c oxidase.
When zinc was enclosed in the interior of cytochrome c oxidase
containing liposomes, the H/e stoichiometry was found to
gradually decrease with increasing Zn2+ concentration. Half-
inhibition of proton pumping was observed at [Zn2+]i = 75 WM
corresponding to about 5^6 Zn2+ ions per oxidase molecule. In
addition, there was a significant increase in the respiratory
control ratio of the proteoliposomes upon incorporation of Zn2+.
Time-resolved potential measurements on a black lipid mem-
brane showed that the electrogenic phases slowed down in the
presence of Zn2+ correspond to phases that have been attributed
to proton uptake from the cytoplasmic side and to proton
pumping. We conclude that Zn2+ ions bind close to or within the
two proton transfer pathways of the bacterial cytochrome c
oxidase. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: Cytochrome c oxidase; Proton pumping; Zn2
binding; Black lipid membrane; Proton slip
1. Introduction
Cytochrome c oxidase (COX, for recent reviews, see [1,2]),
the terminal enzyme of the respiratory chain, catalyzes elec-
tron transfer from cytochrome c to molecular oxygen, reduc-
ing the latter to water. This redox reaction is coupled to pro-
ton translocation across the inner mitochondrial or bacterial
membrane. In most COXs, the proton pumping stoichiometry
is one proton per transferred electron or four protons per
reduced oxygen, although lower ratios have also been re-
ported [3,4].
Two proton transfer pathways have been identi¢ed in the
crystal structure of Paracoccus denitri¢cans COX [5]. The so-
called K-pathway leads from the cytoplasm via Lys-354 (‘K’)
towards the binuclear center whereas the D-pathway proceeds
from Asp-124 (‘D’) via Glu-278 to the region between the two
hemes. Flow-£ash [6,7] and charge translocation measure-
ments [8,9] in combination with site-directed mutagenesis
have shown that the K-pathway is involved in proton uptake
associated with the transfer of the ¢rst two electrons to the
oxidized enzyme whereas the other two substrate protons and
all pumped protons are taken up via the D-pathway.
Zn2 ions have been shown to have a functional, catalytic
or regulatory role for more than 300 proteins [10,11]. In many
cases, zinc is tightly bound to the protein by interaction with
sulfhydryl groups of cysteines and/or imidazole groups of his-
tidines. These tightly bound Zn2 ions cannot be removed by
chelators such as EDTA. Bovine-heart cytochrome c oxidase,
for example, contains a single zinc binding site where the
metal is coordinated to four cysteine residues of subunit Vb
[12]. This site, however, is absent in the bacterial cytochrome
oxidases as they do not have subunits homologous to the
nuclear encoded proteins of eukaryotes. The pool of Zn2
that is not tightly bound to macromolecules has been termed
‘chelatable zinc’ [13] and has been receiving growing attention
over the last decade [14]. Elevated chelatable zinc concentra-
tions have been associated with, e.g. cardiac ischemia and
cardiac in£ammation [15,16] and were shown to be toxic to
neurons [17,18]. The latter was attributed to alterations of
mitochondrial function.
Early studies on intact mitochondria revealed that Zn2
inhibits respiration on substrates that enter the respiratory
chain downstream from complex I [19,20]. This inhibition
was later attributed to Zn2 binding to the cytochrome bc1
complex [21,22]. Indeed, two Zn2 binding sites per cyto-
chrome bc1 monomer were identi¢ed by X-ray crystallography
[23] and located close to the stigmatellin binding site that is
thought to be equivalent to center Qo. Recently, it was shown
that zinc also inhibits the mitochondrial K-ketoglutarate de-
hydrogenase complex upstream from complex I [14].
Here we show that zinc binding to the cytoplasmic side of
P. denitri¢cans COX causes the proton pump to slip, i.e. it
leads to selective uncoupling of proton translocation from
electron transfer. The electrogenic phases slowed down in
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the presence of Zn2 correspond to those that have been at-
tributed to proton uptake from the cytoplasmic side or to
proton pumping. We conclude that Zn2 binding occurs close
to or within the two proton transfer pathways of the enzyme.
These ¢ndings are in good agreement with a recent report by
Aagaard and Brzezinski [24] showing that there is a decrease
in the rates of the PCF and FCO transitions upon Zn2
binding to the solubilized Rhodobacter sphaeroides COX.
2. Materials and methods
2.1. Protein puri¢cation and reconstitution
P. denitri¢cans ATCC 13543 cells were grown, cytoplasmic mem-
branes were isolated, and cytochrome c oxidase was puri¢ed by im-
munoa⁄nity chromatography as described [25]. Horse-heart cyto-
chrome c was purchased from Biomol (Hamburg, Germany) and
used without further puri¢cation.
Proteoliposomes for proton pumping measurements were prepared
by the cholate dialysis method as described in [3] using asolectin
(phosphatidyl choline type II S, Sigma) which was further puri¢ed
as described in [26], at a concentration of 40 mg/ml. Lipids were dried
under vacuum and resuspended in 100 mM HEPES^KOH, pH 7.3, 10
mM KCl, 2% (w/v) cholate. The suspension was stirred on ice for 1^2
h under argon and sonicated to clarity with a Branson soni¢er at 30%
duty cycle (power setting 3). COX was added to a concentration of
4 WM and the mixture was dialyzed against the resuspension bu¡er
without cholate (2U2 h, 10 kDa cut-o¡). Subsequently, asolectin
vesicles were dialyzed against two changes of 10 mM HEPES^
KOH, 50 mM KCl, 50 mM sucrose (12 h each) and two changes of
55 mM KCl, 55 mM sucrose, pH 7.3 (12 h and 4 h). For the incor-
poration of Zn2, the appropriate amount of ZnCl2 was added prior
to sonication, and was also present during the ¢rst three dialysis steps.
The COX concentration after dialysis was determined from the re-
duced minus oxidized optical di¡erence spectrum with O607ÿ630 nm = 23
mM31 cm31. It was found to be 2.5^3 WM. For electrometric mea-
surements COX was reconstituted into Escherichia coli lipid (acetone/
ether preparation; Avanti Biochemicals) liposomes at a lipid/protein
ratio of 20 (w/w) as described [27], using 2% (w/v) sodium cholate as
detergent in 50 mM HEPES^KOH (pH 7.4). The proteoliposomes
were loaded with Zn2 by adding the desired amount of ZnCl2 fol-
lowed by a repeated freeze-thaw-sonicate procedure. External Zn2
was removed by gel ¢ltration, using 0.65 Wm ¢lter units (Millipore)
and Sephadex G50 medium (Pharmacia).
The respiratory control ratio (RCR) was determined as the ratio of
the rates of cytochrome c oxidation in the coupled and uncoupled
states, respectively, essentially as described by Mu«ller et al. [28]. Re-
duced cytochrome c was used at a concentration of 40 WM in 10 mM
HEPES^KOH, 50 mM KCl, 50 mM sucrose, pH 7.3, the rate of its
oxidation was measured by following the change in absorbance at 550
nm after addition of 1.2 nM reconstituted cytochrome c oxidase.
Uncoupling was achieved by addition of 5 WM valinomycin and 10
WM carbonyl cyanide m-chlorophenylhydrazine (CCCP).
2.2. Determination of [Zn2] and trapped volume
The concentration of ZnCl2 within the vesicles was determined by
atomic absorption spectroscopy (Perkin-Elmer AAS 4100, furnace).
The internal volume of the vesicles was estimated by entrapping bro-
mocresol purple (Aldrich) within the liposomes. The dye was added at
a concentration of 100 WM prior to sonication and was also present
during the ¢rst three dialysis steps. The last three dialysis steps were
against 10 mM HEPES^KOH, pH 7.5, 50 mM KCl, 50 mM sucrose.
Relative bromocresol purple concentrations were determined by mea-
suring the absorbance at 590^480 nm (pH 8 minus pH 6). The di¡er-
ence extinction coe⁄cient (590^480 nm, pH 83pH 6) was determined
as 44 000 M31 cm31.
2.3. Proton pumping experiments and electrometric measurements
Proton pumping was measured as the acidi¢cation of the external
medium upon a pulse of reduced cytochrome c using a stopped-£ow
spectrophotometer and phenol red as the pH-sensitive dye [3,29].
Time-resolved potential measurements on the black lipid membrane
were performed under anaerobic conditions using [Ru(2,2P-
bipyridyl)3]Cl2 as electron donor as previously described [9,30].
Brie£y, 40 Wl of proteoliposomes containing P. denitri¢cans COX
(4 WM) and either 0 or 100 WM internal Zn2 were added to 1.3 ml of
bu¡er (50 mM HEPES^KOH, pH 7.4) containing 300 WM potassium
ferricyanide. After the vesicles had attached to the black lipid mem-
brane, 80 WM Ru II (2,2P-bipyridyl)3Cl2 (Rubpy) and 300 WM EDTA
were added and electron injection was induced with a short laser pulse
(10 ns, 451 nm, W100 mJ/cm2). The oxoferryl state F was generated
by addition of a 100-fold excess (10 WM) of hydrogen peroxide.
2.4. Crystallization
Wild-type P. denitri¢cans COX was puri¢ed and crystallized as a
co-complex with an antibody Fv fragment as described by Ostermeier
et al. [31]. 1 mM ZnCl2 was present during crystallization.
3. Results and discussion
Fig. 1 shows the experimental traces of the proton pumping
measurements for Zn2 concentrations inside the vesicles be-
tween 0 and 200 WM. The H/e stoichiometry was determined
from the ratio of the amplitudes of the absorbance changes in
the coupled (trace a) and the decoupled state (trace b). Stoi-
chiometries varied slightly for di¡erent cytochrome c oxidase
containing vesicle (COV) preparations and were determined to
be between 0.8 and 1 in the absence of Zn2 inside the
vesicles. In the presence of the metal, a gradual decrease in
the H/e ratio with increasing [Zn2]i was observed, with half-
inhibition of proton pumping occurring at a concentration of
W75 WM (Table 1). The rate of cytochrome c oxidation, how-
ever, was only slightly a¡ected by the presence of Zn2, re-
maining s 70% at Zn2 concentrations below 300 WM (see
Table 1). No decoupling of proton pumping from catalytic
turnover was observed when Zn2 ions were present outside
the vesicles, even at a concentration of 500 WM (not shown).
Fig. 1. Proton pumping assay using a stopped-£ow spectrophotome-
ter. pH changes were monitored by following the change in absor-
bance of phenol red at the isosbestic point of horse-heart cyto-
chrome c. COVs were diluted to [COX] = 0.5 WM in 55 mM KCl,
55 mM sucrose, pH 7.3, 55 WM phenol red, 5 WM valinomycin and
mixed with 16 WM ferrocytochrome c in 55 mM KCl, 55 mM su-
crose, pH 7.3 (all concentrations after mixing). a, COVs without
Zn2 ; b, as a, in the presence of 5 WM CCCP; c^e, COVs with in-
ternal Zn2 concentrations of 15, 75 and 200 WM, respectively.
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Determination of [Zn2]i by atomic absorption spectrosco-
py showed that the absolute amount of zinc present after
dialysis was about ¢ve times lower than that added initially.
This is in good agreement with the result of the measurement
of the average internal volume of the vesicles that was found
to be 20% of the overall volume. Hence the trapped volume
corresponds to about 4^6 l/mol phospholipid which is in the
typical range for large unilamellar vesicles obtained by deter-
gent dialysis [32]. Thus, with [Zn2]1=2 = 75 WM and a COX
concentration after dialysis of 2.5^3 WM, a ¢ve- to six-fold
excess of Zn2 over COX was su⁄cient for half-inhibition
of proton pumping.
The decrease in the H/e ratio with increasing [Zn2]i was
paralleled by an increase in the respiratory control ratio which
was found to rise by a factor of 3 between 0 and 500 WM
Zn2. This result implicates that the permeability of the pro-
teoliposome membrane for H is lowered in the presence of
internal Zn2. It has been proposed that a large part of the
proton leakage through the vesicular membrane occurs via the
incorporated protein, because 10 times higher RCRs were
obtained when a COX from a di¡erent source was reconsti-
tuted, under otherwise identical conditions [3]. Thus, the in-
crease in the RCR observed here is probably due to Zn2
inhibiting proton leakage through the enzyme by binding
close to or within the proton-conducting pathways of COX.
Selective uncoupling of proton translocation from cyto-
chrome c oxidation has been reported for E. coli ubiquinol
oxidase [33,34] and P. denitri¢cans COX [35] with mutations
close to the entrance of the D-pathway. In the case of the E.
coli enzyme, replacement of Asp-124 (P. denitri¢cans number-
ing) by asparagine led to an enzyme that retained 45% of its
catalytic activity but was unable to pump protons. A similar
result was obtained with an Asn-199-Asp mutant of the P.
denitri¢cans enzyme whereas a Asn-131-Asp mutant showed a
so-called ideally decoupled phenotype with full enzymatic ac-
tivity but no proton pumping. Mutation of the central residue
of the K-pathway, Lys-354, to methionine yielded an enzyme
with very low activity [36] and a binuclear center that is di⁄-
cult to reduce [37]. However, £ow-£ash experiments with the
fully reduced COX [7] and measurement of proton pumping
coupled to the peroxidase half cycle of the enzyme [38]
showed that during the oxidative part of the catalytic reaction
the Lys-354-Met mutant behaves similar to the wild-type.
Thus, the selective inhibition of proton pumping indicates
that Zn2 binding somehow impedes proton transfer along
the D-pathway, but an additional e¡ect on the proton con-
ductivity of the K-pathway cannot be ruled out.
To distinguish between the two pathways, we have inves-
tigated the electrogenic events associated with the uptake of
the ¢rst and fourth electrons in the catalytic cycle, i.e. the
OCE and FCO transitions. It has been reported that uptake
of the ¢rst electron by the oxidized enzyme is coupled to
proton uptake via the K-pathway [9] whereas the FCO tran-
sition was shown to be linked to proton uptake and proton
translocation via the D-pathway [8]. Our results are summa-
rized in Fig. 2 and Table 2. Two electrogenic phases are ob-
served when an electron is injected into oxidized COX. They
have time constants of d1 = 22 Ws and d2 = 176 Ws and have
been associated with electron transfer from CuA to heme a
and proton uptake from the cytoplasmic side via the K-path-
way, respectively [9]. In the presence of Zn2 inside the pro-
teoliposomes at a concentration of 100 WM, the time constant
of the ¢rst phase was slightly larger (34 Ws) whereas the sec-
ond phase was signi¢cantly slower, with d2 = 1.4 ms. A similar
Table 1
Proton pumping stoichiometries, relative RCRs and turnover rates
for COVs with di¡erent internal Zn2 concentrations
[Zn2]i (WM) H/e (rel.) RCR (rel.) Rate (s31)
0 1a 4.5b 166c
15 0.9 6.3 147
30 0.9 5.9 164
50 0.6 7.2 139
75 0.5 8.3 135
100 0.4 8.6 156
300 0.2 12.2 120
500 0.1 13.5 90
1000 n.d. 18.5 51
The turnover rate was determined under decoupled conditions (5 WM
valinomycin, 10 WM CCCP). The error for all values is W10%.
aDepending on the COV preparation, H/e ratios varied between
0.8 and 1.1. Values shown are relative stoichiometries ({H/e}Zn/
{H/e}3Zn) for COVs from the same batch, i.e. if the measured value
for {H/e}Zn was 0.45 and the {H/e}3Zn was 0.9 for COVs from
the same batch, than {H/e}rel: = 0.5.
bVaried between 2.8 and 5.8 among di¡erent COV batches. As for
H/e, the RCRs are relative values for vesicles from the same batch.
cBetween 160 and 170 s31 for di¡erent COV preparations.
Fig. 2. Changes in electric potential observed upon one-electron reduction of the oxidized enzyme (OCE, left) and the oxoferryl state (FCO,
right). The Zn2 concentration inside the vesicles was either 0 or 100 WM. Conditions were as described in [9] and Section 2. The traces in
each panel have been normalized to the amplitude of the fast phase to aid visual comparison of the kinetics.
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increase in the time constants of the phases linked to proton
transfer was observed for the FCO transition: In the absence
of Zn2, three phases with time constants of d1 = 26 Ws,
d2 = 270 Ws and d3 = 1.5 ms were observed, in good agreement
with the results reported by Konstantinov et al. [8]. The three
phases have been attributed to electron transfer from CuA to
heme a (fast phase), proton uptake via the D-pathway (inter-
mediate phase) and proton pumping, again via the D-pathway
(slow phase). When Zn2 was incorporated into the proteoli-
posomes, the ¢rst phase was only slightly a¡ected (d1 = 33 Ws)
whereas the other two phases were slowed down dramatically
to d2 = 1.9 ms and d3 = 13 ms. In addition, the relative ampli-
tudes of the phases attributed to proton transfer were signi¢-
cantly smaller in the presence of Zn2. Thus, it can be con-
cluded that Zn2 ions inside the vesicles lead to inhibition of
proton transfer along both the D- and the K-pathway.
Recently, Aagaard and Brzezinski described a decrease in
the rates of the PCF and FCO transitions upon Zn2 bind-
ing, as measured with the £ow-£ash technique [24]. In the
presence of 100 WM Zn2 the overall transition rates dropped
to 6200 (PCF) and 360 s31 (FCO) compared to 10 000 and
820 s31 in the absence of Zn2, respectively. Our results on
the FCO transition, namely a decrease in rate from 3700 to
520 and from 670 to 75 s31 for the two phases associated with
proton transfer, qualitatively agree with the data from [24].
However, a direct comparison of the actual numbers is
di⁄cult because (1) the results described in [24] were obtained
with the solubilized enzyme whereas we have used proteolipo-
somes, (2) Zn2 ions were present at the given concentration
in the surrounding medium in [24] whereas here they were
trapped within the proteoliposomes with access only to the
cytoplasmic side of the enzyme, (3) Aagaard and Brzesinski
report overall transition rates determined spectrophotometri-
cally whereas we have measured the di¡erent phases of charge
translocation, and (4) the enzymes were from di¡erent sources
(R. sphaeroides vs. P. denitri¢cans).
A similar retardation of proton transfer in the presence of
Zn2 ions has been reported for the mammalian cytochrome
bc1 complex [22] and the bacterial photosynthetic reaction
center [39]. In the latter case, binding of Zn2 or Cd2 led
to a marked decrease in the rate of the second electron trans-
fer from QA to QB. This electron transfer is coupled to proton
transfer from the cytoplasmic surface to QB. Normally, the
proton transfer is much faster than the electron transfer, but
in the presence of Zn2 or Cd2 it becomes the rate-limiting
process. The metal binding site was identi¢ed by X-ray crys-
tallography as being close to the cytoplasmic surface of the
protein, with Zn2 or Cd2 being coordinated to an aspartic
acid and two histidine residues [40]. For the identi¢cation of
the metal binding site in COX, we have crystallized the en-
zyme in the presence of Zn2. Unfortunately, suitable crystals
could only be obtained at pH 5.5, and even only a slight
increase in pH resulted in destruction of the crystals. As a
result, in the crystal structure, determined at 3 Aî resolution,
no bound Zn2 was found. We attribute this to histidines
being doubly protonated at this acidic pH and therefore un-
able to serve as metal ligands. Thus, it can only be speculated
about the location of the binding site(s). The simplest explan-
ation of the inhibitory e¡ect of Zn2 on proton transfer is that
it binds to groups ^ possibly histidines and acidic amino acid
side chains ^ that normally serve as transient proton donors
or acceptors. Close to the entrance of the D-pathway, three
residues, Asn-27, His-28 and Asp-124 are arranged in a way
(geometry, distance) that could allow for speci¢c binding of a
metal ion, thereby blocking proton uptake via Asp-124. Alter-
natively, Zn2 might not directly coordinate to amino acid
residues participating in proton transfer, but could block pro-
ton transfer by disturbing the arrangement of water molecules
in the pathways or by electrostatic repulsion of incoming pro-
tons.
4. Conclusion
Our results show that binding of Zn2 to the cytoplasmic
side of bacterial COX reduces the proton conductivity of the
two proton transfer pathways, resulting in uncoupling of pro-
ton translocation from electron transfer and an elevated res-
piratory control ratio. Electrometric measurements indicate
that both the D- and the K-pathway are a¡ected by Zn2
binding, but the exact location of the metal site(s) remains
to be identi¢ed.
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